NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $358,000 | +7060.0% | 26,700 | +184.0% | 0.02% | – |
| Q2 2022 | $5,000 | -89.4% | 9,400 | +7.4% | 0.00% | -100.0% |
| Q1 2022 | $47,000 | +51.6% | 8,750 | -57.1% | 0.00% | +200.0% |
| Q4 2021 | $31,000 | -82.5% | 20,400 | +338.7% | 0.00% | -87.5% |
| Q3 2021 | $177,000 | +52.6% | 4,650 | +26.4% | 0.01% | +60.0% |
| Q2 2021 | $116,000 | -47.5% | 3,680 | -8.5% | 0.01% | -54.5% |
| Q1 2021 | $221,000 | +132.6% | 4,020 | +629.6% | 0.01% | +120.0% |
| Q4 2020 | $95,000 | +21.8% | 551 | -90.7% | 0.01% | 0.0% |
| Q3 2020 | $78,000 | -8.2% | 5,900 | -62.7% | 0.01% | -16.7% |
| Q2 2020 | $85,000 | +431.2% | 15,800 | +1875.0% | 0.01% | +500.0% |
| Q1 2020 | $16,000 | -75.0% | 800 | -83.7% | 0.00% | -75.0% |
| Q4 2019 | $64,000 | +128.6% | 4,900 | -33.8% | 0.00% | +100.0% |
| Q3 2019 | $28,000 | -82.1% | 7,400 | -19.6% | 0.00% | -86.7% |
| Q2 2019 | $156,000 | +345.7% | 9,200 | +80.4% | 0.02% | +275.0% |
| Q1 2019 | $35,000 | +1066.7% | 5,100 | +750.0% | 0.00% | – |
| Q4 2018 | $3,000 | -96.4% | 600 | -93.8% | 0.00% | -100.0% |
| Q3 2018 | $84,000 | -87.3% | 9,621 | -54.7% | 0.01% | -88.9% |
| Q2 2018 | $662,000 | +1149.1% | 21,246 | +62.2% | 0.05% | +1250.0% |
| Q1 2018 | $53,000 | -81.9% | 13,100 | +104.1% | 0.00% | -66.7% |
| Q4 2017 | $293,000 | -61.3% | 6,418 | -70.0% | 0.01% | -58.6% |
| Q3 2017 | $757,000 | -59.2% | 21,396 | -77.7% | 0.03% | -58.0% |
| Q2 2017 | $1,854,000 | +166.4% | 95,875 | +136.2% | 0.07% | +146.4% |
| Q1 2017 | $696,000 | +404.3% | 40,596 | +84.0% | 0.03% | +460.0% |
| Q4 2016 | $138,000 | +7.0% | 22,062 | +137.1% | 0.01% | -16.7% |
| Q3 2016 | $129,000 | -78.0% | 9,306 | -78.5% | 0.01% | -80.0% |
| Q2 2016 | $587,000 | -46.2% | 43,314 | -55.9% | 0.03% | -58.3% |
| Q1 2016 | $1,091,000 | +104.3% | 98,248 | +116.1% | 0.07% | +140.0% |
| Q4 2015 | $534,000 | – | 45,467 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |